Research suggests that Tongkat Ali is recognized within the broader category of adaptogens — botanicals traditionally associated with helping the body manage stress and fatigue — though the current evidence base for this specific application remains limited and difficult to evaluate consistently. The available literature on this topic, represented here by a single 2025 narrative review, focuses less on measuring Tongkat Ali's direct effects on stress outcomes and more on the regulatory and methodological inconsistencies that make it difficult to draw firm conclusions about any adaptogen's efficacy. Studies indicate that the same plant can be evaluated under vastly different scientific and legal standards depending on the country and intended use, which complicates efforts to build a reliable body of evidence. Readers should be aware that a single narrative review represents a relatively early stage of evidence synthesis, and that more controlled clinical trials specifically examining Tongkat Ali's effects on stress-related outcomes would be needed before stronger conclusions could be drawn.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Two Sides of the Same Coin for Health: Adaptogenic Botanicals as Nutraceutica... | Review | 2025 | — | 72 |